Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfecta

Eur J Cancer. 1996 Feb;32A(2):369-70. doi: 10.1016/0959-8049(95)00573-0.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antimetabolites, Antineoplastic / adverse effects*
  • Breast Neoplasms / drug therapy*
  • Dihydrouracil Dehydrogenase (NADP)
  • Female
  • Fluorouracil / adverse effects*
  • Humans
  • Middle Aged
  • Osteogenesis Imperfecta / complications*
  • Oxidoreductases / deficiency*

Substances

  • Antimetabolites, Antineoplastic
  • Oxidoreductases
  • Dihydrouracil Dehydrogenase (NADP)
  • Fluorouracil